The Enterprise Value as of November 2024 (TTM) for Emmaus Life Sciences, Inc. (EMMA) is 33.54M

According to Emmaus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 33.54M. This represents a change of -6.74% compared to the average of 35.96M of the last 4 quarters.

Emmaus Life Sciences, Inc. (EMMA) Historical Enterprise Value (quarterly & annually)

How has EMMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Emmaus Life Sciences, Inc. over the last ten years is 40.49M. The current 33.54M Enterprise Value has changed 8.18% with respect to the historical average. Over the past ten years (40 quarters), EMMA's Enterprise Value was at its highest in in the September 2019 quarter at 120.63M. The Enterprise Value was at its lowest in in the September 2016 quarter at 2.99M.

Emmaus Life Sciences, Inc. (EMMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Emmaus Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Emmaus Life Sciences, Inc. (EMMA) Average Enterprise Value

How has EMMA Enterprise Value performed in the past?

The current Enterprise Value of Emmaus Life Sciences, Inc. (EMMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Emmaus Life Sciences, Inc. (EMMA) Enterprise Value vs. Peers

How is EMMA’s Enterprise Value compared to its peers?

Emmaus Life Sciences, Inc.’s Enterprise Value is greater than NRx Pharmaceuticals, Inc. (20.26M), greater than Kaleido Biosciences, Inc. (4.26K), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Scopus BioPharma Inc. (-111950.00), less than Cell Source, Inc. (0), less than Adhera Therapeutics, Inc. (34.64M), greater than PolarityTE, Inc. (10.81M), greater than ZIVO Bioscience, Inc. (-6308329.00), less than Anebulo Pharmaceuticals, Inc. (73.95M), less than Adagene Inc. (36.46M), greater than Acrivon Therapeutics, Inc. Common Stock (22.22M), less than AnaptysBio, Inc. (163.47M), less than Mineralys Therapeutics, Inc. (502.56M), less than null (523.81M),

Build a custom stock screener for Emmaus Life Sciences, Inc. (EMMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmaus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emmaus Life Sciences, Inc. (EMMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emmaus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.